43 min listen
New Lipid-Lowering Therapies in Atherosclerotic Cardiovascular Disease: Who, How, When, and for How Long?
FromKeeping Current
New Lipid-Lowering Therapies in Atherosclerotic Cardiovascular Disease: Who, How, When, and for How Long?
FromKeeping Current
ratings:
Length:
17 minutes
Released:
Sep 14, 2023
Format:
Podcast episode
Description
Are you up to date on the latest lipid-lowering therapies? Drs Zambon and Taub discuss. Credit available for this activity expires: 9/13/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/996295?ecd=bdc_podcast_libsyn_mscpedu
Released:
Sep 14, 2023
Format:
Podcast episode
Titles in the series (99)
Reducing the Risks of Hyperkalemia in the Treatment of Heart Failure and Chronic Kidney Disease: What It Means for Management Teams: Did you know that up to 47% of patients taking renin-angiotensin-aldosterone system inhibitors see their therapy discontinued after developing mild or moderate-to-severe hyperkalemia? Credit available for this activity expires: 5/31/24 Earn Credit /... by Keeping Current